Nestin
Nestin is a type 6 intermediate filament (IF) protein that is expressed in stem cells of the central nervous system (CNS) during development. It is a marker for multipotent neural stem cells, and its expression diminishes when the cells differentiate. Nestin has been widely used in research as a primary indicator of neural stem cell potential.
Structure[edit]
Nestin is a large protein, with a molecular weight of approximately 220 kDa. It is characterized by a central α-helical rod domain flanked by non-α-helical N-terminal (head) and C-terminal (tail) domains. The rod domain is responsible for the assembly of nestin into intermediate filaments, while the head and tail domains are thought to mediate interactions with other cellular structures and proteins.
Function[edit]
Nestin plays a crucial role in the development of the nervous system. It is expressed in dividing cells during the early stages of embryogenesis, and its expression is maintained in areas of the brain where neurogenesis continues into adulthood, such as the subventricular zone and the dentate gyrus of the hippocampus. Nestin-positive cells have the ability to differentiate into neurons, astrocytes, and oligodendrocytes, the three main cell types of the CNS.
In addition to its role in neurogenesis, nestin is also expressed in other types of stem cells, including those found in the pancreas, prostate, and hair follicle. This suggests that nestin may have a more general role in stem cell biology.
Clinical significance[edit]
Alterations in nestin expression have been associated with a variety of pathological conditions. For example, nestin is re-expressed in the brain following injury, suggesting a role in the regenerative response. In addition, nestin expression is often upregulated in cancer, including glioblastoma, the most aggressive type of brain tumor. This has led to the suggestion that nestin could be used as a marker for cancer stem cells.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
